Drugs / Elemental calcium
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT02143505 | Mar 2014 → Feb 2017 | colorectal adenoma | Shanghai Jiao Tong University School of Medicine | Unknown | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT00228033 | Apr 2002 → Dec 2005 | postpartum depression | Oregon Health and Science University | Completed | No outcome recorded |
Also used as a comparator or background therapy in 2 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT06045351 Background | Jan 2024 → Jun 2026 overdue | anovulation | Aga Khan University | Recruiting | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT02021864 Background | Jan → Oct 2014 | pregnancy disorder | Dr. Sima Hashemipour | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | elemental calcium | “daily prenatal multivitamin containing elemental calcium 250 mg/day and vitamin D3 400 unit” NCT02021864 ↗3“elemental calcium 1200mg/d plus vitamin D3 250 IU/d daily supplements” NCT02143505 ↗ “Elemental calcium 1000 mg/day” NCT06045351 ↗ |